Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-04-28

FDA Approved: KETOROLAC TROMETHAMINE — Supplemental Application (FOSUN PHARMA USA INC)

View source ↗

Summary

FDA approved a supplemental application for ketorolac tromethamine from Fosun Pharma USA Inc, under the ANDA pathway.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ketorolac tromethamine (Ketorolac tromethamine)

Snippet

SUPPL AP for KETOROLAC TROMETHAMINE (KETOROLAC TROMETHAMINE)